Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3gcq | 1BU | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 3hv3 | R49 | Mitogen-activated protein kinase 14 | / | 0.617 | |
| 3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.602 | |
| 2bak | AQZ | Mitogen-activated protein kinase 14 | / | 0.535 | |
| 3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.535 | |
| 4a9y | AQZ | Mitogen-activated protein kinase 14 | / | 0.535 | |
| 3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.525 | |
| 3iw8 | HIZ | Mitogen-activated protein kinase 14 | / | 0.516 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.514 | |
| 2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 4few | PP2 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.489 | |
| 3njo | PYV | Abscisic acid receptor PYR1 | / | 0.488 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.483 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.480 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 4eyj | N61 | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.478 | |
| 1w83 | L11 | Mitogen-activated protein kinase 14 | / | 0.477 | |
| 3n3z | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.476 | |
| 3pg3 | DG7 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 1w7h | 3IP | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.466 | |
| 4feu | 537 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.466 | |
| 2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.463 | |
| 3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.463 | |
| 3l9m | L9M | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.461 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.461 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.460 | |
| 3h3r | 14H | Collagen type IV alpha-3-binding protein | / | 0.460 | |
| 4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.458 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.456 | |
| 2yvw | EPU | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.456 | |
| 3p9t | TCL | Repressor | / | 0.456 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 3hbf | MYC | Flavonoid 3-O-glucosyltransferase | 2.4.1 | 0.453 | |
| 4fex | 0TO | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.452 | |
| 3q2m | CKI | Spectinomycin phosphotransferase | / | 0.451 | |
| 4qys | PLR | Tryptophan synthase beta chain 2 | 4.2.1.20 | 0.451 | |
| 1uwh | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.450 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.450 | |
| 4g2l | 0WL | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.450 | |
| 2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.449 | |
| 3d7z | GK5 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.448 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.447 | |
| 1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.447 | |
| 2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.447 | |
| 4k9y | K9Y | Focal adhesion kinase 1 | 2.7.10.2 | 0.447 | |
| 1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
| 2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.446 | |
| 4b2g | V1N | Uncharacterized protein | / | 0.446 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.444 | |
| 3g4k | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
| 3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.444 | |
| 1og5 | SWF | Cytochrome P450 2C9 | / | 0.443 | |
| 2j3j | HC4 | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.443 | |
| 2uag | UMA | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.443 | |
| 4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.443 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.443 | |
| 1soj | IBM | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.442 | |
| 3ngl | NAP | Bifunctional protein FolD | / | 0.442 | |
| 4ttj | FMC | Purine nucleoside phosphorylase DeoD-type | / | 0.442 | |
| 3c36 | KAI | Glutamate receptor ionotropic, kainate 1 | / | 0.441 | |
| 3nxo | D2B | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 3rth | RTH | Beta-secretase 1 | 3.4.23.46 | 0.440 | |
| 4a4o | 664 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.440 |